Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gordon MS et al. – Although the RECIST RR of 11% did not exceed prespecified estimates for additional study, single–agent erlotinib yielded disease control and survival outcomes of interest with an expected toxicity profile. The design of future trials of the EGFR axis in pRCC should be based on preclinical or molecular data that define appropriate patient subgroups, new drug combinations, or potentially more active alternative schedules.


Today in Hematology/Oncology...keeping you current

Loss of expression of TIMP3 in clear cell renal cell carcinoma
European Journal of Cancer, 03/18/10

Primary Ewings sarcoma/primitive neuroectodermal tumor of the kidney that responded to low-dose chemotherapy with ifosfamide, etoposide, and doxorubicin
International Journal of Clinical Oncology, 03/18/10

Small interference RNA targeting Kruppel-like factor 8 inhibits the renal carcinoma 786-0 cells growth in vitro and in vivo
Journal of Cancer Research & Clinical Oncology, 03/18/10

Today in Pharmacology/kinetics...keeping you current

Randomized, Double-Blind, Controlled Study of Losartan in Children with Proteinuria
Clinical Journal of the American Society of Nephrology, 03/19/10

Effect of Prenatal Dexamethasone on Postnatal Serum and Urinary Angiotensin II Levels
American Journal of Hypertension, 03/19/10

Sodium bicarbonate in preventing contrast nephropathy in patients at risk for volume overload: a randomized controlled trial
Journal of Nephrology, 03/18/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address